A case of synchronous multiple primary lung cancers each harboring an EGFR mutation or an ALK fusion gene alone that responded to osimertinib with chemotherapy
Doppo Fukui, Daisuke Morinaga, Jun Sakakibara-Konishi, Yukiko Yoshida et autres
jp (code pays fourni par la source)
1 citation
Respiratory Investigation